Korean J Prev Med.
1999 Jun;32(2):123-129.
A Case-Control Study on Effects of Genetic Polymorphisms of GSTM1, GSTT1, CYP1A1 and CYP2E1 on Risk of Lung Cancer
- Affiliations
-
- 1Department of Preventive Medicine, College of Medicine, Chungbuk National University, Korea.
- 2Department of Internal Medicine, College of Medicine, Chungbuk National University, Korea.
- 3 Department of Orthopaedic Surgery, College of Medicine, Chungbuk National University, Korea.
Abstract
OBJECTIVES
This study was performed to investigate effects of genetic polymorphisms of
glutathione S-transferase M1 (GSTM1), glutathione S-transferase M1 (GSTT1),
cytochrome P450 1A1 (CYP1A1) and cytochrome P450 2E1 (CYP2E1) on lung cancer
development.
METHODS
Ninety-eight lung cancer patients and 98 age-sex matched non-cancer patients
hospitalized in Chungbuk National University Hospital from March 1997 to August 1998,
were the subjects of this case-control study. Direct interview was done and genotypes
of GSTM1, GSTT1, CYP1A1 and CYP2E1 were investigated using multiplex PCR or
PCR-RFLP methods with DNA extracted from venous blood. Effects of the
polymorphisms of GSTM1, GSTT1, CYP1A1 and CYP2E1, lifestyle factors including
smoking, and their interactions on lung cancer were statistically analyzed.
RESULTS
GSTM1 was deleted in 67.01% of the cases and 58.16% of the controls, and the
odds ratio(95% CI) was 1.46(0.82-2.62). GSTT1 deletion was 58.76% for the lung cancer
patients and 50.00% for the controls OR:1.43(0.81-2.51). The frequencies of Ile/Ile,
Ile/Val and Val/Val of the CYP1A1 polymorphisms were 59.18%, 35.71%, and 5.10% for
the cases, and 52.04%, 45.92%, 2.04% for the controls, respectively. Risk of lung cancer
was not associated with polymorphism of CYP1A1 (x2trend=0.253, p-value>0.05). The
respective frequency of c1/c1, c1/c2, c2/c2 genotypes for CYP2E1 were 50.00%, 42.86%,
7.14% for the lung cancer patients, and 66.33%, 30.61%, 3.06% for the controls
(x2trend=5.783, p<0.05). c2 allele was a significant risk factor for lung cancer. We also
observed a significant association of cigarette smoking history with lung cancer risk.
The odds ratio(95% CI) of cigarette smoking was 3.03(1.58-5.81). In multiple logistic
analysis including genotypes of GSTM1, GSTT1, CYP1A1 and CYP2E1, and smoking
habit, only smoking habit came out to be a significant risk factor for lung cancer.
CONCLUSION
Genetic polymorphisms of GSTM1, GSTT1, CYP1A1 and CYP2E1 are not so
strongly associated with lung cancer as lifestyle factors including cigarette smoking.